Cyberknife treatment for advanced or terminal stage hepatocellular carcinoma
نویسندگان
چکیده
منابع مشابه
Capecitabine for treatment of advanced hepatocellular carcinoma.
BACKGROUND/AIMS Patients with advanced hepatocellular carcinoma (HCC) face a dismal prognosis, as no effective palliative chemotherapy exists. Moreover, treatment of patients with hepatocellular carcinoma presents a major challenge, because associated cirrhosis limits the choice of chemotherapeutic agents. We evaluated the activity and toxicity of capecitabine in patients with advanced hepatoce...
متن کاملPreclinical studies of 166Ho-chitosan for treatment of hepatocellular carcinoma
Introduction: Recently, due to the special characteristics of 166Ho and chitosan, 166Ho-chitosan complex was developed for treatment of tumors such as hepatocellular carcinoma. This complex has been lately prepared with high radiochemical purity in our lab. The preclinical studies of the complex however should be performed to evaluate the tracer concentration in target and...
متن کاملRegional cancer chemotherapy for advanced stage hepatocellular carcinoma.
The conventional treatment for hepatocellular carcinoma (HCC) has been surgical resection. typically by segmentectomy. lobectomy. or trisegmentectomy. The large majority of patients. however. cannot have their tumors resected. either because of underlying cirrhosis and liver damage. making resection hazardous. or because of the multifocal or bilobar spread of the hepatoma. In those patients wit...
متن کاملComparative research on the efficacy of CyberKnife® and surgical excision for Stage I hepatocellular carcinoma
OBJECTIVE To retrospectively analyze and compare the outcomes of patients with hepatocellular carcinoma treated with either surgical excision or CyberKnife® from September 2006 to August 2011. MATERIALS AND METHODS Local control and toxicity were the primary endpoints, followed by local progression-free survival, progression-free survival, and overall survival as the secondary endpoints. Resp...
متن کاملTreatment of Stage IVA Hepatocellular Carcinoma Should
Main Outcome Measures: Intraoperative data, recurrence, and long-term survival rates were analyzed. Results: Postoperative mortality and morbidity were 5% and 30%, respectively. The median number of resected tumors per patient was 3, and the median diameter of the largest tumor was 60 mm. With a median follow-up of 23 months, 14 patients (70%) developed recurrence. Treatment of recurrence was p...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: World Journal of Gastroenterology
سال: 2015
ISSN: 1007-9327
DOI: 10.3748/wjg.v21.i46.13101